Circle IPO'nun hedefinde 5 milyar dolarlık bir değerleme yer alıyor. Stablecoin konseptli bir hisse senedi var mı?

Inspire Medical Systems

company

About

Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.

  • 101 - 250

Details

Last Funding Type
Series B
Last Funding Money Raised
$17M
Industries
Biotechnology,Health Care,Medical Device,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
101 - 250
Operating Status
Active

Inspire Medical Systems is a developer of innovative, implantable neurostimulation technologies to treat Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from the fields of cardiac pacing and neurostimulation, Inspire has developed a proprietary Upper Airway Stimulation (UAS) therapy for patients who suffer from OSA.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$109.50M
Inspire Medical Systems has raised a total of $109.50M in funding over 2 rounds. Their latest funding was raised on Nov 18, 2016 from a Series F round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 18, 2016 Series F $38M 1 Detail
May 15, 2014 Series E $40M 2 Detail
May 11, 2012 Series C $14.50M 2 Medtronic Detail
Jun 29, 2009 Series B $17M 1 Detail

Investments

Number of Investments
Number of Lead Investments
1
1
Inspire Medical Systems has made 1 investments. Their most recent investment was on Apr 27, 2022, when EnsoData raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 27, 2022 EnsoData
Series A $20M Analytics Yes

Investors

Number of Lead Investors
Number of Investors
1
2
Inspire Medical Systems is funded by 2 investors. Medtronic and GDN Holdings are the most recent investors.
Investor Name Lead Investor Funding Round
Medtronic Series F
GDN Holdings Series E